Philip Morris International Inc (PM.N)

PM.N on New York Stock Exchange

85.15USD
21 Aug 2014
Price Change (% chg)

$0.06 (+0.07%)
Prev Close
$85.09
Open
$85.23
Day's High
$85.69
Day's Low
$85.13
Volume
659,427
Avg. Vol
1,271,655
52-wk High
$91.81
52-wk Low
$75.28

PM.N

Chart for PM.N

About

Philip Morris International Inc. (PMI) is a holding company. PMI’s subsidiaries and affiliates and their licensees are engaged in the manufacture and sale of cigarettes and other tobacco products in markets outside of the United States of America. Its products are sold in approximately 180 countries. The Company divides its... (more)

Overall

Beta: 0.92
Market Cap (Mil.): $132,921.70
Shares Outstanding (Mil.): 1,562.13
Dividend: 0.94
Yield (%): 4.42

Financials

  PM.N Industry Sector
P/E (TTM): 22.09 27.32 34.10
EPS (TTM): 3.85 -- --
ROI: 29.99 0.56 50.17
ROE: -- 0.73 58.54
Search Stocks

Czech Philip Morris H1 net profit up 23 percent

PRAGUE, Aug 19 - Consolidated net profit at Czech tobacco group Philip Morris CR rose 23 percent to 1.1 billion crowns ($52.67 million) in the first half, helped by better pricing in its markets.

19 Aug 2014

RPT-FEATURE-Tobacco-derived 'plantibodies' enter the fight against Ebola

NEW YORK, Aug 6 - Drugmakers' use of the tobacco plant as a fast and cheap way to produce novel biotechnology treatments is gaining global attention because of its role in an experimental Ebola therapy.

06 Aug 2014

Tobacco-derived 'plantibodies' enter the fight against Ebola

NEW YORK - Drugmakers' use of the tobacco plant as a fast and cheap way to produce novel biotechnology treatments is gaining global attention because of its role in an experimental Ebola therapy.

06 Aug 2014

Tobacco-derived 'plantibodies' enter the fight against Ebola

NEW YORK - Drugmakers' use of the tobacco plant as a fast and cheap way to produce novel biotechnology treatments is gaining global attention because of its role in an experimental Ebola therapy.

06 Aug 2014

FEATURE-Tobacco-derived 'plantibodies' enter the fight against Ebola

NEW YORK, Aug 6 - Drugmakers' use of the tobacco plant as a fast and cheap way to produce novel biotechnology treatments is gaining global attention because of its role in an experimental Ebola therapy.

06 Aug 2014

UPDATE 2-Essentra profit rises as cigarette filter sales grow

* Shares rise as much as 3.5 pct (Adds details, CEO comment, share price)

31 Jul 2014

RPT-Fitch Affirms Philip Morris International at 'A'; Outlook Stable

July 8 - (The following statement was released by the rating agency)

08 Jul 2014

Philip Morris seeks review of EU tobacco law

LONDON, June 27 - Marlboro cigarette maker Philip Morris International is seeking to challenge Europe's new laws on tobacco products, the latest clash between Big Tobacco and governments seeking tighter regulation.

27 Jun 2014

Marlboro maker Philip Morris cuts 2014 earnings forecast

- Cigarette maker Philip Morris International Inc cut its earnings forecast for 2014 and said it is proving to be a "complex and truly atypical" year for the company.

26 Jun 2014

UPDATE 1-Marlboro maker Philip Morris cuts 2014 earnings forecast

* Cuts 2014 profit est to $4.87-$4.97 per shr from $5.09-$5.19 per shr

26 Jun 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MarketLine (a Datamonitor Company)
£114.00
Provider: S&P Capital IQ – STARS Reports
£75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks